Catalyst Wire Dossier Catalyst Wire Dossier

IC351

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IC351, covering 2008-06-30 to 2008-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction [Phase 2]

See pricing